Skip to main content
. 2020 Sep 15;11:562137. doi: 10.3389/fphar.2020.562137

Table 1.

Clinical and sociodemographic characteristics of patients with major depressive disorder.

placebo + propofol ketamine + propofol p
n 16 11
Age (years) 59.60 (15.71) 57.34 (13.02) 0.69
Gender M/F 9/7 7/4 0.70
Unipolar/bipolar depression (n) 13/3 11/0 0.25
Treatment resistant depression (n) 13 11 0.25
MADRS score 35.44 (4.77) 36.73 (8.81) 0.62
MMSE score 27.4 (2.4) 26.7 (4.7) 0.66
Prior suicide attempts (n) 0.5 (0.9) 1.5 (1.4) 0.07
ECT parameters
 Seizure threshold (mC) 119.7 (109.8) 94.40 (62.15) 0.51
 Number of sessions 9.62 (4.51) 10.18 (4.42) 0.75
 EEG seizure duration (s) 29.42 (12.66) 20.12 (6.82) 0.036*
 Clinical seizure duration (s) 19.95 (9.74) 12.54 (3.78) 0.025*
 RUL/BT 6/10 5/6 0.68

The results are given as the mean (standard deviation).

RUL, right unilateral; BT, bitemporal.

*means statistically significant.